Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 14, 2021
The IMA Group (IMA) announced the acquisition of Diagnostics Research Group (DXRG), a clinical research site in San Antonio, Texas, with expertise across a diverse array of medical specialties, including vaccine and medical device development, ...
read more
Thursday, January 12, 2023
The IMA Group (IMA) has completed the acquisition of Clinical Trials of America (CTA), a multi-therapeutic clinical trials company that brings to IMA four new independent and six embedded site locations in Louisiana and North Carolina.
read more
The Contract Network, a startup collaboration platform focused on radically accelerating contract negotiations and simplifying contract compliance, has entered into a know-how agreement with Mayo Clinic to build a solution that will simplify the ...
read more
Tuesday, February 16, 2021
The CM Group has announced the acquisition of Scientific Commercialization, a Madison, Wisconsin-based business focused on medical affairs consulting and business intelligence software solutions.
read more
Thursday, January 09, 2020
The Clarke Companies has added Covex to its portfolio of businesses.
read more
Your input is important as we benchmark current global and regional trends affecting the bioindustry. You will receive, a FREE Aggregated Summary of the results of this important global study, a FREE White Paper - Top Trends in Biopharmaceutical ...
read more
The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on metagenomics and novel enzyme discovery. The R&D work concerned is set to be carried out ...
read more
Monday, February 06, 2023
The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and the Health Equity in Clinical Trials Congress this month. The AOD will become the first entity to represent industry in ...
read more
TFS HealthScience (TFS), a global contract research organization (CRO), announced the appointment of long-standing member of the company, Miriam Martin , as Vice President of Business Development, Clinical Development Services (CDS).
read more
Thursday, November 03, 2022
TFF Pharmaceuticals announced a collaboration with Aptar Pharma aimed at developing and testing the administration of dry powder vaccines utilizing TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose (...
read more
TFF Pharmaceuticals announced the USPTO has issued a Notice of Allowance for U.S. Patent Application No. 12/778,795, "Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing."
read more
TFF Pharmaceuticals, Inc. and Catalent announced their collaboration agreement focused on the generation, testing and manufacture of dry powder formulations for a range of biotherapeutics through the application of TFF Pharmaceuticals’ patented Thin ...
read more
Tuesday, January 13, 2015
Platinum Press, Inc. (PPI) – a leading provider of healthcare packaging solutions for the pharmaceutical, medical device and animal care sectors that specializes in labels, folding cartons, blister packaging, inserts/outserts and medication guides – ...
read more
Wednesday, September 11, 2019
Kinaxis will help Teva connect its data, processes and people into a single platform to transform its global supply chain, improve visibility and operational efficiencies.
read more
Thursday, February 08, 2018
During the fourth quarter of 2017, the company noted further deterioration in the U.S. generics market and economic environment.
read more